Jul 16, 2020 / 11:00AM GMT
Jonas Jarvius - Q-linea AB - CEO
Thank you very much for that announcement and I welcome you all for this report for the second quarter of 2020. Before I go into any details around the call, I suggest we look at slide number 2, which is our disclaimer slide, indicates me or Anders could make any forward-looking statements.
Having had a look at that, we move to slide number 3. I would just like to start with saying that Q-linea as a company, our mission and vision is really to develop disruptive solutions for faster infectious disease diagnostics. Our first application will target sepsis. But, of course, we will also look at many other possible applications in the future.
On the slide number 3, you can also see very highlights of the quarter. I think we have had an extremely strong quarter, the second quarter of this year. The team has been working truly dedicated towards our goal for the upcoming launch of ASTar. It's also been a particularly active quarter together with Thermo Fisher Scientific where we expand and broaden the partnership and really do our best within the two
Q2 2020 Q Linea AB Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers